AHR and cancer: Given the proven cross-talk between AHR and MAPK pathway [15] and the role of AHR in modulating growth and migration of cancer cells [12], in the present work we aim to confirm previous associations between the BRAFV600E and AHR overexpression in a large, independent cohort of patients with PTC.